Photo: imaginima / iStock / Getty Images
(Iowa) -- Iowa is joining a coalition of 43 states and territories seeking court approval of a $400 million dollar settlement with two generic drug manufacturers.
The settlement would resolve allegations against Sandoz, Inc. and Fougera Pharmaceuticals that the drug manufacturers artificially inflated and manipulated prices and limited competition. A preliminary motion for approval of the settlement is being filed in the United States District Court of Connecticut in Hartford. Iowa's share of the current settlement $1,380,384,01.
The latest settlement comes as the first trial in the case is set to be held in Hartford, Connecticut, in February of next year. Iowa is part of a coalition of states and territories that launched a series of antitrust cases beginning in 2016. The members of the coalition include:
- Alaska
- Arizona
- California
- Colorado
- Connecticut
- Delaware
- District of Columbia
- Idaho
- Illinois
- Indiana
- Iowa
- Kansas
- Kentucky
- Maine
- Maryland
- Massachusetts
- Michigan
- Minnesota
- Mississippi
- Nebraska
- Nevada
- New Hampshire
- New Jersey
- New Mexico
- New York
- North Carolina
- North Dakota
- Northern Mariana Islands
- Ohio
- Oklahoma
- Oregon
- Pennsylvania
- Puerto Rico
- Rhode Island
- South Dakota
- Tennessee
- U.S. Virgin Islands
- Vermont
- Virginia
- Washington
- West Virginia
- Wisconsin
- Wyoming
Anyone who purchased a generic drug listed here may be eligible for compensation. Those who think they may be eligible for compensation can call toll-free at 1-866-290-0182, email info@AGGenericDrugs.com, or visit www.AGGenericDrugs.com.